Scoping review identifies factors associated with the onset of infant acute lymphoblastic leukaemia January 31, 2025 Scoping review identifies factors associated with the onset of infant acute lymphoblastic leukaemia
Lucía Fanlo and Biola M. Javierre receive the Fundació Agrupació award for their research on pediatric acute lymphoblastic leukemia December 01, 2021 Lucía Fanlo and Biola M. Javierre receive the Fundació Agrupació award for their research on pediatric acute lymphoblastic leukemia
Manel Esteller recognized as Highly Cited Researcher 2021 by Clarivate Web of Science November 19, 2021 Manel Esteller recognized as Highly Cited Researcher 2021 by Clarivate Web of Science
New strategies in the fight against leukemia at the Science Week 2021 November 18, 2021 New strategies in the fight against leukemia at the Science Week 2021
Dr. Manel Esteller receives the Fernández-Cruz Award for excellence in biomedical research November 16, 2021 Dr. Manel Esteller receives the Fernández-Cruz Award for excellence in biomedical research
Dr. Manel Esteller awarded the E-nnova Health 2021 Award in Big Data and Artificial Intelligence November 11, 2021 Dr. Manel Esteller awarded the E-nnova Health 2021 Award in Big Data and Artificial Intelligence
Manel Esteller receives the Narcís Monturiol Medal for scientific and technological merit from the Generalitat de Catalunya. November 08, 2021 Manel Esteller receives the Narcís Monturiol Medal for scientific and technological merit from the Generalitat de Catalunya.
A new way to distinguish red blood cells from whites using flow cytometry. November 04, 2021 A new way to distinguish red blood cells from whites using flow cytometry.
Dr. Manel Esteller, director of the Josep Carreras Leukaemia Research Institute, recognized among the researchers with the most scientific impact according to Stanford University November 02, 2021 Dr. Manel Esteller, director of the Josep Carreras Leukaemia Research Institute, recognized among the researchers with the most scientific impact according to Stanford University
Researchers at the Josep Carreras Institute find inhibition of CBP/p300 may enhance sensitivity of MDS cells to azacytidine October 18, 2021 Researchers at the Josep Carreras Institute find inhibition of CBP/p300 may enhance sensitivity of MDS cells to azacytidine
Epigenetics predicts the efficacy of T-lymphocyte treatments in hematological malignancies September 29, 2021 Epigenetics predicts the efficacy of T-lymphocyte treatments in hematological malignancies
